Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Pharmacists' Perspectives on Prescribing and Expanding Access to Hormonal Contraception in Pharmacies in the United States.

Rafie S, Cieri-Hutcherson NE, Frame TR, Griffin B, Harris JB, Horlen C, Shealy K, Stein AB, Stone RH, Vest K, Westberg S, Yancey AM.

J Pharm Pract. 2019 Aug 7:897190019867601. doi: 10.1177/0897190019867601. [Epub ahead of print]

PMID:
31390938
2.

Pharmacist Outlooks on Prescribing Hormonal Contraception Following Statewide Scope of Practice Expansion.

Rafie S, Richards E, Rafie S, Landau SC, Wilkinson TA.

Pharmacy (Basel). 2019 Jul 18;7(3). pii: E96. doi: 10.3390/pharmacy7030096.

3.

Emergency Contraception Counseling in California Community Pharmacies: A Mystery Caller Study.

Ditmars L, Rafie S, Kashou G, Cleland K, Bayer L, Wilkinson TA.

Pharmacy (Basel). 2019 Apr 23;7(2). pii: E38. doi: 10.3390/pharmacy7020038.

4.

Results of a Naloxone Screening Quality-Improvement Project in an Academic Emergency Department.

Devries J, Rafie S, Ajayi TA, Kreshak A, Edmonds KP.

J Emerg Med. 2019 Apr;56(4):378-385. doi: 10.1016/j.jemermed.2018.12.029. Epub 2019 Feb 13.

PMID:
30770141
5.

Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.

Lu S, Rafie S, Hamper J, Strauss R, Kroon L.

Contraception. 2019 Apr;99(4):239-243. doi: 10.1016/j.contraception.2018.12.002. Epub 2018 Dec 16.

PMID:
30562478
6.

Pharmacist and student pharmacist perspectives on providing preconception care in the United States.

Ng C, Najjar R, DiPietro Mager N, Rafie S.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):426-431. doi: 10.1016/j.japh.2018.04.020. Epub 2018 Jun 5.

PMID:
29884475
7.

Medication abortion: Potential for improved patient access through pharmacies.

Raifman S, Orlando M, Rafie S, Grossman D.

J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4):377-381. doi: 10.1016/j.japh.2018.04.011. Epub 2018 May 8.

8.

An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.

Batra P, Rafie S, Zhang Z, Singh AV, Bird CE, Sridhar A, Sullivan JG.

Obstet Gynecol. 2018 May;131(5):850-855. doi: 10.1097/AOG.0000000000002572.

PMID:
29630024
9.

Guide for Drug Selection During Pregnancy and Lactation: What Pharmacists Need to Know for Current Practice.

Griffin BL, Stone RH, El-Ibiary SY, Westberg S, Shealy K, Forinash A, Yancey A, Vest K, Karaoui LR, Rafie S, Horlen C, Lodise N, Cieri-Hutcherson N, McBane S, Simonyan A.

Ann Pharmacother. 2018 Aug;52(8):810-818. doi: 10.1177/1060028018764447. Epub 2018 Mar 9.

PMID:
29519141
10.

Evaluating Community Pharmacy Responses About Levonorgestrel Emergency Contraception by Mystery Caller Characteristics.

Wilkinson TA, Rafie S, Clark PD, Carroll AE, Miller E.

J Adolesc Health. 2018 Jul;63(1):32-36. doi: 10.1016/j.jadohealth.2017.11.303. Epub 2018 Feb 21.

PMID:
29475729
11.

A Multi-hospital Before-After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors.

Schnock KO, Dykes PC, Albert J, Ariosto D, Cameron C, Carroll DL, Donahue M, Drucker AG, Duncan R, Fang L, Husch M, McDonald N, Maddox RR, McGuire J, Rafie S, Robertson E, Sawyer M, Wade E, Yoon CS, Lipsitz S, Bates DW.

Drug Saf. 2018 Jun;41(6):591-602. doi: 10.1007/s40264-018-0637-3.

PMID:
29411338
12.

Role of the community pharmacist in emergency contraception counseling and delivery in the United States: current trends and future prospects.

Rafie S, Stone RH, Wilkinson TA, Borgelt LM, El-Ibiary SY, Ragland D.

Integr Pharm Res Pract. 2017 Mar 23;6:99-108. doi: 10.2147/IPRP.S99541. eCollection 2017. Review.

13.

Older teen attitudes toward birth control access in pharmacies: a qualitative study.

Wilkinson TA, Miller C, Rafie S, Landau SC, Rafie S.

Contraception. 2018 Mar;97(3):249-255. doi: 10.1016/j.contraception.2017.11.008. Epub 2017 Dec 7.

PMID:
29223497
14.

Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.

Vu K, Rafie S, Grindlay K, Gutierrez H, Grossman D.

J Pharm Pract. 2019 Feb;32(1):54-61. doi: 10.1177/0897190017737897. Epub 2017 Nov 2.

PMID:
29096570
15.

Emergency Contraception Algorithm and Guide for Clinicians.

Stone R, Rafie S, El-Ibiary SY, Vernon V, Lodise NM.

Nurs Womens Health. 2017 Aug - Sep;21(4):297-305. doi: 10.1016/j.nwh.2017.06.005.

PMID:
28784210
16.

Access to Emergency Contraception After Removal of Age Restrictions.

Wilkinson TA, Clark P, Rafie S, Carroll AE, Miller E.

Pediatrics. 2017 Jul;140(1). pii: e20164262. doi: 10.1542/peds.2016-4262.

17.

Transdermal delivery of combined hormonal contraception: a review of the current literature.

Galzote RM, Rafie S, Teal R, Mody SK.

Int J Womens Health. 2017 May 15;9:315-321. doi: 10.2147/IJWH.S102306. eCollection 2017. Review.

18.

Implementing an overdose education and naloxone distribution program in a health system.

Devries J, Rafie S, Polston G.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S154-S160. doi: 10.1016/j.japh.2017.01.002. Epub 2017 Feb 21.

PMID:
28233681
19.

The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study.

Schnock KO, Dykes PC, Albert J, Ariosto D, Call R, Cameron C, Carroll DL, Drucker AG, Fang L, Garcia-Palm CA, Husch MM, Maddox RR, McDonald N, McGuire J, Rafie S, Robertson E, Saine D, Sawyer MD, Smith LP, Stinger KD, Vanderveen TW, Wade E, Yoon CS, Lipsitz S, Bates DW.

BMJ Qual Saf. 2017 Feb;26(2):131-140. doi: 10.1136/bmjqs-2015-004465. Epub 2016 Feb 23.

PMID:
26908900
20.

Provider Opinions Regarding Expanding Access to Hormonal Contraception in Pharmacies.

Rafie S, Kelly S, Gray EK, Wong M, Gibbs S, Harper CC.

Womens Health Issues. 2016 Mar-Apr;26(2):153-60. doi: 10.1016/j.whi.2015.09.006. Epub 2015 Nov 6. Erratum in: Womens Health Issues. 2017 Jul - Aug;27(4):509.

PMID:
26549241

Supplemental Content

Loading ...
Support Center